Simple jQuery Dropdowns
Please use this identifier to cite or link to this item: http://repository.li.mahidol.ac.th/dspace/handle/123456789/31925
Title: Phenobarbital-induced severe cutaneous adverse drug reactions are associated with CYP2C19*2 in Thai children
Authors: Wiparat Manuyakorn
Khanitha Siripool
Wasu Kamchaisatian
Samart Pakakasama
Anannit Visudtibhan
Soamarat Vilaiyuk
Thidarat Rujirawat
Suwat Benjaponpitak
Mahidol University
Keywords: Immunology and Microbiology;Medicine
Issue Date: 1-May-2013
Citation: Pediatric Allergy and Immunology. Vol.24, No.3 (2013), 299-303
Abstract: Background: Aromatic anticonvulsant-induced severe cutaneous adverse drug reactions (SCARs), including Stevens-Johnson syndrome (SJS), toxic epidermal necrosis (TEN), and drug rash with eosinophilia and systemic symptoms (DRESS), are fatal immune-mediated adverse drug reactions. CYP2C19, a cytochrome P450 isoform, plays a role in metabolic rate of aromatic anticonvulsant. HLA-B*1502 has also been demonstrated to be associated with carbamazepine-induced SJS-TEN. Methods: Forty case patients who were diagnosed with SCARs after initiation of phenobarbital (PB), phenytoin (PHT), or carbamazepine (CBZ) for 1-8 wk and forty control patients who received PB, PHT, or CBZ at least 2 months with no adverse drug reactions were enrolled in the study. The genotypes of CYP2C19*1, CYP2C19*2, and HLA-B*1502 were analyzed using allele-specific polymerase chain reaction technique. Clinical characteristics of SCARs patients who used different drugs were also analyzed. Results: There was no significant difference in sex, onset of symptoms, laboratory results, treatment, and length of stay among patients with SCARs due to PB, PHT, or CBZ. The patients with CYP2C19*2 variant had a trend to have a likelihood to develop SCARs more than the patients with CYP2C19 wild type (OR = 2.5, 95% CI (0.96-67.3) p = 0.06). In subgroup analysis, the patients with CYP2C19*2 variant were at four times increased risk of SCARs from phenobarbital more than the patients with CYP2C19 wild type (OR = 4.5, 95% CI (1.17-17.37) p < 0.03). There was no association between the HLA-B*1502 and aromatic anticonvulsant-induced severe cutaneous adverse reactions (SCARs). Conclusion: CYP2C19*2 variant may play a role in the genetic predisposition of SCARs from phenobarbital. © 2013 John Wiley & Sons A/S.
URI: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84876438516&origin=inward
http://repository.li.mahidol.ac.th/dspace/handle/123456789/31925
ISSN: 13993038
09056157
Appears in Collections:Scopus 2011-2015

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.